| Document Type
|
:
|
BL
|
| Record Number
|
:
|
864803
|
| Title & Author
|
:
|
Hallucinations in psychoses and affective disorders : : a clinical and biological approach /\ Paolo Brambilla, Massimo Carlo Mauri, Alfredo Carlo Altamura, editors.
|
| Publication Statement
|
:
|
Cham :: Springer,, [2018]
|
|
|
:
|
, ©2018
|
| Page. NO
|
:
|
1 online resource :: illustrations (some color)
|
| ISBN
|
:
|
3319751247
|
|
|
:
|
: 3319751255
|
|
|
:
|
: 9783319751245
|
|
|
:
|
: 9783319751252
|
|
|
:
|
3319751239
|
|
|
:
|
9783319751238
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references.
|
| Contents
|
:
|
Intro; Presentation; Contents; Contributors; Part I: Neurotransmission and Psychopathology; 1: Substances of Abuse and Hallucinogenic Activity: The Dopaminergic Pathway -- Focus on Cocaine and Amphetamine-type Stimulants; 1.1 Focus on Cocaine; 1.1.1 Molecular Mechanism; 1.1.2 Conclusions; 1.2 Focus on Amphetamine-Type Stimulants; 1.2.1 Molecular Mechanism; 1.2.2 Conclusions; References; 2: Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway -- Focus on Classical Hallucinogens and Entactogens; 2.1 Focus on Classical Hallucinogens; 2.1.1 Molecular Mechanism
|
|
|
:
|
2.1.2 Conclusions2.2 Focus on Entactogens; 2.2.1 Molecular Mechanism; 2.2.2 Conclusions; References; 3: Substances of Abuse and Hallucinogenic Activity: The Glutamatergic Pathway -- Focus on Ketamine; 3.1 Focus on Ketamine; 3.1.1 Molecular Mechanism; References; 4: Chronic Hallucinatory Disorder "an Equivalent" of Delusional Disorder; 4.1 Introduction; 4.2 Hallucinatory Disorder: Clinical Picture; 4.3 Hallucinatory Disorder: Neurocognitive Aspects; 4.4 Hallucinatory Disorder: Neuroimaging Data; References; 5: Hallucinations in the Substance-Induced Psychosis; 5.1 Introduction
|
|
|
:
|
5.1.1 Symptoms5.1.2 Epidemiology; 5.1.3 Differential Diagnosis; 5.2 Substance-Induced Psychosis Versus Primary Psychosis; 5.2.1 Treatments; 5.2.2 Prognosis; 5.2.3 Prevention; 5.3 Stimulant Drug-Induced Psychosis; 5.3.1 Amphetaminic Substances; 5.3.1.1 Therapy; 5.3.2 MDMA (Ecstasy); 5.3.2.1 Therapy; 5.3.3 Cocaine; 5.3.3.1 Therapy; 5.4 Hallucinogenic Drug-Induced Psychosis; 5.4.1 Phencyclidine and Ketamine; 5.4.2 LSD; 5.4.3 Therapy; 5.5 Cannabis-Induced Psychosis; 5.5.1 Therapy; 5.6 Alcohol-Induced Psychosis; 5.6.1 Therapy; Bibliography
|
|
|
:
|
6: Hallucinatory Symptomatology in Major Psychoses (Schizophrenia and Bipolar Disorders)6.1 Introduction; 6.2 Hallucinations in Bipolar Disorder Versus Schizophrenia: A Concise Look at the Status of Comparative Empirical Research; 6.3 A Phenomenological Reappraisal of BD and Schizophrenia; 6.4 The Psychotic Syndrome as a Trajectory; References; 7: Hallucinations in Neurological Disorders; 7.1 Hypnic Hallucinations (HH); 7.2 Peduncular Hallucinosis (PH); 7.3 Charles Bonnet Syndrome (CBS); 7.4 Migraine; 7.5 Epilepsy; 7.6 Intellectual Disability; 7.7 Neurodegenerative Disorders
|
|
|
:
|
7.7.1 Alzheimer's Disease (AD)7.7.2 Parkinson's Disease (PD); 7.7.3 Dementia with Lewy Bodies (DLB); 7.7.4 Frontotemporal Dementia (FTD); 7.8 Prion Diseases; 7.9 Hallucinations Associated with Other Medical Conditions; 7.9.1 Delirium; 7.9.2 Paraneoplastic Neurological Syndromes; 7.9.3 Systemic Lupus Erythematosus (SLE); 7.9.4 Hashimoto's Encephalopathy; 7.9.5 Behçet's Syndrome; 7.9.6 Neurosyphilis; 7.9.7 Inborn Errors of Metabolism; References; Part II: Genetics and Neuroimaging; 8: Genetic Basis of Auditory Verbal Hallucinations in Schizophrenia; 8.1 Introduction
|
| Abstract
|
:
|
This book presents state of the art knowledge on the psychopathology, clinical symptomatology, biology, and treatment of hallucinations in patients with psychoses and affective disorders. The opening section describes and examines the origins of the hallucinatory symptoms associated with schizophrenia, bipolar disorders, and drug- or substance-induced psychoses. In addition, progress in understanding of hallucinations in children and adolescents and chronic hallucinatory disorder is reviewed, and the value of a Research Domain Criteria approach in elucidating the emergence of auditory hallucinations is explained. The biological basis of hallucinations is then closely scrutinized with reference to recent genetic research, neurochemical studies, and functional and structural neuroimaging data. Outcomes of a meta-analysis of diffusion tensor imaging studies regarding the association between white matter integrity and auditory verbal hallucinations are highlighted. The closing chapters focus on the roles of drug treatment and electric and magnetic brain stimulation techniques. The book will be of wide interest to psychiatrists and clinical psychologists.
|
| Subject
|
:
|
Affective disorders.
|
| Subject
|
:
|
Hallucinations and illusions.
|
| Subject
|
:
|
Psychoses.
|
| Subject
|
:
|
Affective disorders.
|
| Subject
|
:
|
Hallucinations and illusions.
|
| Subject
|
:
|
HEALTH FITNESS-- Diseases-- General.
|
| Subject
|
:
|
MEDICAL-- Clinical Medicine.
|
| Subject
|
:
|
MEDICAL-- Diseases.
|
| Subject
|
:
|
MEDICAL-- Evidence-Based Medicine.
|
| Subject
|
:
|
MEDICAL-- Internal Medicine.
|
| Subject
|
:
|
Psychiatry.
|
| Subject
|
:
|
Psychoses.
|
| Subject
|
:
|
Hallucinations.
|
| Dewey Classification
|
:
|
616.89
|
| LC Classification
|
:
|
RC553.H3
|
| NLM classification
|
:
|
WM 204
|
| Added Entry
|
:
|
Altamura, Alfredo Carlo
|
|
|
:
|
Brambilla, Paolo
|
|
|
:
|
Mauri, Massimo Carlo
|